COMMUNIQUÉS West-GlobeNewswire

Gritstone Oncology Reports Third Quarter 2018 Financial Results and Recent Business Highlights
14/11/2018
Successful Initial Public Offering Raises $95.6 Million in Net Proceeds EMERYVILLE, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing [...]
Reflect Scientific Reports Strong Sales - Cryometrix Freezers Lead
14/11/2018
OREM, Utah, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (OTC:RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries announces a 27% year [...]
NanoVibronix Provides Business Update for the Third Quarter of 2018
14/11/2018
Lays out key upcoming milestones for the next 12 months ELMSFORD, N.Y., Nov. 14, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low [...]
Entasis Therapeutics Reports Third Quarter 2018 Financial Results and Provides Business Update
14/11/2018
Completed $75.0 million initial public offering in September Reported positive Phase 2 topline results of lead program ETX2514SUL On-track to initiate two Phase 3 clinical trials in 2019 WALTHAM, Mass., Nov. 14, 2018 ( [...]
Eidos Therapeutics to Present at Two Upcoming Investor Conferences
14/11/2018
SAN FRANCISCO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX) today announced that management will present a company overview at two upcoming investor conferences. Piper Jaffray [...]
Rexahn Pharmaceuticals Announces Leadership Transition
14/11/2018
Douglas Swirsky Assumes Role of Chief Executive Officer ROCKVILLE, Md., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing [...]
PotNetwork Holdings’ Diamond CBD Engages With Fellow Industry Leaders at MJBizCon
14/11/2018
Diamond CBD Features Latest Products at Booth 4517 , During Marijuana Business Daily’s Flagship Event at the Las Vegas Convention Center FORT LAUDERDALE, Fla., Nov. 14, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- [...]
Spectral Announces Third Quarter Results
14/11/2018
TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX: EDT) , a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced its [...]
Cue Biopharma to Host Business Update Call and Webcast
14/11/2018
CAMBRIDGE, Mass., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human [...]
RedHill Biopharma Announces Presentation on YELIVA® (opaganib) for Multiple Myeloma at EORTC-NCI-AACR Symposium
14/11/2018
TEL-AVIV, Israel and RALEIGH, N.C., Nov. 14, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Canntab Corporate Update
14/11/2018
TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited ( CSE: PILL , FSE: TBF1) (“Canntab” or the “Company”) is a company with a clear vision of becoming the leader in solid oral dosage formulation of [...]
MacroGenics Announces Poster Presentation on Preclinical PD-L1 x CD137 DART® Program at the EORTC-NCI-AACR Symposium in Dublin
14/11/2018
ROCKVILLE, MD, Nov. 14, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
CURE Pharmaceutical Names Veteran Executive as Chief Financial Officer
14/11/2018
OXNARD, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has tapped Alex Katz to be the company’s Chief Financial Officer [...]
Iterum Reports Third Quarter 2018 Financial Results and Recent Highlights
14/11/2018
DUBLIN, Ireland and CHICAGO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company developing anti-infectives against multi-drug resistant pathogens, today [...]
Aleafia Health to Launch Global Cannabis Education Platform with D2L
14/11/2018
Platform to Provide Cannabis Education Courses TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF: OTCQX: ALEAF, FRA: ARAH) (“ Aleafia ”) has entered into a global agreement with D2L ( [...]
Axsome Therapeutics Announces Completion of Patient Enrollment in the ASCEND Phase 2 Trial of AXS-05 in Major Depressive Disorder
14/11/2018
NEW YORK, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Trillium Therapeutics Reports Third Quarter 2018 Financial and Operating Results
14/11/2018
Positive clinical update on the intratumoral trial of TTI-621, a CD47 immune checkpoint inhibitor, presented at the 2018 EORTC CLTF meeting Positive clinical update on the intravenous trial of TTI-621 presented at the [...]
Evogene Reports Third Quarter 2018 Financial Results
14/11/2018
REHOVOT, Israel, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Conference call and webcast, today at 9:00 am Eastern Time Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science [...]
Athenex, Inc. Announces Third Quarter 2018 Financial Results and Provides Corporate Update
14/11/2018
Third quarter revenue increased to $18.4 million compared to $14.0 million in 3Q 2017 Positive recommendation by DSMB upon second interim analysis for Oraxol Phase III program KX2-391 Phase III pivotal studies achieved [...]

Pages